Dr Mark Trozzi（マーク・トロッツィ博士）がCOVID-19 mRNAワクチンによる障害報告に関する査読済み論文の約1,000件を掲載したサイトを作っています。
1000 peer reviewed articles on “Vaccine” injuries
その中で9番目に多くの件数が報告されている「心筋心膜炎（Myopericarditis）」の論文リストを転載させていただきます。
急性心膜炎の合併症であり、心膜炎症の心筋への進展が特徴で、トロポニン値の上昇として現れる。一般に急性心膜炎として評価され、治療される。
心膜というのは，心臓の外側を包むように覆う膜のことです。心臓の外側にひっついている臓側心膜と，心臓を取り囲む周りの組織にひっついている壁側心膜の 2 枚からなります。この 2 枚の心膜の間には狭い隙間が空いていて，心膜腔と呼んでいます。心膜炎は両心膜および心膜腔に炎症が生じる病気です。しばしば心膜腔に液体が貯留します。「心臓に水が貯まっている」といわれる状態になるのです。
しばしば胸に痛みを感じますが、息を吸い込んだときにその痛みが強くなります。
たまに心臓の壁（心筋壁）にも炎症が波及して、心筋炎を併発することもあります（心膜心筋炎）。
Total Papers: 21
Myopericarditis after Pfizer mRNA COVID-19 vaccination in adolescents:
https://www.sciencedirect.com/science/article/pii/S002234762100665X
Myopericarditis after vaccination with COVID-19 mRNA in adolescents 12 to 18 years of age:
https://www.sciencedirect.com/science/article/pii/S0022347621007368
Important information on myopericarditis after vaccination with Pfizer COVID-19 mRNA in adolescents: https://www.sciencedirect.com/science/article/pii/S0022347621007496
Insights from a murine model of COVID-19 mRNA vaccine-induced myopericarditis: could accidental intravenous injection of a vaccine induce myopericarditis
https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab741/6359059
Acute myocarditis after administration of BNT162b2 vaccine against COVID-19:
https://www.sciencedirect.com/science/article/abs/pii/S188558572100133X
Insights from a murine model of myopericarditis induced by COVID-19 mRNA vaccine: could accidental intravenous injection of a vaccine induce myopericarditis:
https://pubmed.ncbi.nlm.nih.gov/34453510/
COVID-19 mRNA vaccination and development of CMR-confirmed myopericarditis:
https://www.medrxiv.org/content/10.1101/2021.09.13.21262182v1.full?s=09
.
Intravenous injection of coronavirus disease 2019 (COVID-19) mRNA vaccine can induce acute myopericarditis in a mouse model:
https://t.co/j0IEM8cMXI
Myopericarditis in a previously healthy adolescent male after COVID-19 vaccination: Case report:
https://pubmed.ncbi.nlm.nih.gov/34133825/
Report of a case of myopericarditis after vaccination with BNT162b2 COVID-19 mRNA in a young Korean male:
https://pubmed.ncbi.nlm.nih.gov/34636504/
Myopericarditis after Pfizer messenger ribonucleic acid coronavirus coronavirus disease vaccine in adolescents:
https://pubmed.ncbi.nlm.nih.gov/34228985/
Acute myopericarditis after COVID-19 vaccine in adolescents:
https://pubmed.ncbi.nlm.nih.gov/34589238/
Nygaard, U., Holm, M., Bohnstedt, C., Chai, Q., Schmidt, L. S., Hartling, U. B., . . . Stensballe, L. G. (2022). Population-based Incidence of Myopericarditis After COVID-19 Vaccination in Danish Adolescents. Pediatr Infect Dis J, 41(1), e25-e28.doi:10.1097/INF.0000000000003389.
https://www.ncbi.nlm.nih.gov/pubmed/34889875
Schauer, J., Buddhe, S., Colyer, J., Sagiv, E., Law, Y., Mallenahalli Chikkabyrappa, S., & Portman, M. A. (2021). Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents. J Pediatr, 238, 317-320.doi:10.1016/j.jpeds.2021.06.083.
https://www.ncbi.nlm.nih.gov/pubmed/34228985
Kohli, U., Desai, L., Chowdhury, D., Harahsheh, A. S., Yonts, A. B., Ansong, A., . . . Ang, J. Y. (2021). mRNA Coronavirus-19 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study. J Pediatr. doi:10.1016/j.jpeds.2021.12.025.
https://www.ncbi.nlm.nih.gov/pubmed/34952008
Long, S. S. (2021). Important Insights into Myopericarditis after the Pfizer mRNA COVID-19 Vaccination in Adolescents. J Pediatr, 238, 5.doi:10.1016/j.jpeds.2021.07.057.
https://www.ncbi.nlm.nih.gov/pubmed/34332972
McLean, K., & Johnson, T. J. (2021). Myopericarditis in a previously healthy adolescent male following COVID-19 vaccination: A case report. Acad Emerg Med, 28(8), 918-921.doi:10.1111/acem.14322.
https://www.ncbi.nlm.nih.gov/pubmed/34133825
Umei, T. C., Kishino, Y., Shiraishi, Y., Inohara, T., Yuasa, S., & Fukuda, K. (2021). Recurrence of myopericarditis following mRNA COVID-19 vaccination in a male adolescent. CJC Open.doi:10.1016/j.cjco.2021.12.002.
https://www.ncbi.nlm.nih.gov/pubmed/34904134
Das, B. B., Kohli, U., Ramachandran, P., Nguyen, H. H., Greil, G., Hussain, T., . . . Khan, D. (2021). Myopericarditis after messenger RNA Coronavirus Disease 2019 Vaccination in Adolescents 12 to 18 Years of Age. J Pediatr, 238, 26-32 e21. doi:10.1016/j.jpeds.2021.07.044.
https://www.ncbi.nlm.nih.gov/pubmed/34339728
Gatti, M., Raschi, E., Moretti, U., Ardizzoni, A., Poluzzi, E., & Diemberger, I. (2021). Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase. Vaccines (Basel), 9(1). doi:10.3390/vaccines9010019.
https://www.ncbi.nlm.nih.gov/pubmed/33406694
Myopericarditis in a previously healthy adolescent male after COVID-19 vaccination: Case report: https://pubmed.ncbi.nlm.nih.gov/34133825/
